Edition:
United Kingdom

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

5.38HKD
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
HK$5.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
70,092,753
52-wk High
HK$13.93
52-wk Low
HK$5.09

Summary

Name Age Since Current Position

Y Y Tse

25 2015 Executive Chairlady of the Board

Ping Tse

66 2016 Chief Executive Officer, Executive Director

Cheung Ling Cheng

54 2017 Executive Vice Chairlady of the Board

Minggang Wang

61 2008 Vice Chairman of the Board and the General Manager of Qingdao Haier

Chun Ling Li

46 Vice President - Finance of CT Tianqing

Hsin Tse

48 Vice President, Executive Director

Mingqin Li

59 2015 Vice President, Executive Director

Fai Chia

2015 Assistant to the President and Vice President

Jinming Li

53 2016 Vice President of CT Tianqing

Xiquan Zhang

48 2015 Vice President of R&D of CT Tianqing and Director of the CT Tianqing R&D Institute

Xinglong Zhuang

48 2016 Vice President of CT Tianqing

Fajun Cai

48 General Manager of the sales Department of CT Tianqing

Ren Li

45 General Manager - of Qingdao CT

Haihua Liu

54 General Manager - of Jiangsu CT Fenghai

Xiaoguang Shen

44 2015 Assistant to President and the General Manager of the Investment Management Department

Wenjun Shi

45 General Manager of the sales Department of CT Tianqing

Hsuan Tse

48 2008 General Manager - Information Management Department

Hong Wang

54 2016 General Manager - Channel Division of CT Tianqing

Qiang Yao

46 General Manager of Sales Department of CT Tianqing

Wei Nong Ye

55 Assistant President, General Manager - R&D Department

Yong Zhu

51 2015 General Manager of Jiangsu Qingjiang

Yangsheng Chen

50 Deputy General Manager - of R&D of Qingdao CT

Kuanqi Wang

51 2016 Senior Deputy General Manager - NJCTT

Yangqing Zhang

49 Deputy General Manager of Finance Department of NJCTT

Zhenqian Zhang

48 Executive Deputy General Manager - NJCTT

Sheng Chen

38 Financial Controller and Deputy General Director

Chau Ling Yu

Assistant Vice President, Financial Controller

Zhoushan Tian

54 2015 Executive Director

Shanchun Wang

50 2015 Executive Director

Hui Cheng

54 Deputy Financial Controller

Zhaoshu Gu

58 Senior Engineer

Fangzhui Hu

45 Vice President of CT Tianqing

Zong Liu

53 Senior Engineer

Kong Tai

47 Managing Director Of Beijing Tide

Zhaocheng Tang

51 Vice President - CT Tianqing

Wun Tse

2015 Assistant to the President

Hongqi Wang

52 Deputy General Manager of NJCTT

Xiangjian Wang

47 Vice President of CT Tianqing

Wenyu Xia

49 2014 General Manager and Director of Jiangsu Fenghai

Ziping Xu

62 Senior Engineer

Jie Zhang

47 Vice President - CT Tianqing.

Ling Zhang

44 Deputy General Manager and the Secreatary to the board of directors of NJCTT

Oi Nin Chan

50 2015 Company Secretary

Dakui Li

74 2004 Independent Non-Executive Director

Hong Lu

48 2015 Independent Non-Executive Director

Zhengfei Lu

55 2005 Independent Non-Executive Director

Lu Fu Zhang

61 2015 Independent Non-Executive Director

Biographies

Name Description

Y Y Tse

Ms. Tse Y Y serves as Executive Chairlady of the Board of the Company since 30 June, 2015. Miss Tse the Chairlady of the Board, an Executive Director, and the Chairman of the Executive Board Committee and the Nomination Committee, respectively, of the Company. Miss Tse is also a director of CT Tianqing and the vice chairlady of Beijing Tide. She holds a Bachelor Degree of Science in Economics from the Wharton School of University of Pennsylvania. Throughout her coursework, she focused on the study of Finance and Healthcare. Previously, she worked in the investment, finance and business development departments of several companies. As a new generation business leader, Miss Tse was recognized as one of the “Most Outstanding Business Women in China for 2018” by Forbe China online. Miss Tse is the daughter of Mr. Tse Ping and Ms. Cheng Cheung Ling, both being Executive Directors and substantial shareholders of the Company, and she is also a niece of each of Mr. Tse Hsin, an Executive Director of the Company, Ms. Chia Fai, Miss Tse Wun, and Mr. Tse Hsuan, Johnny, all being senior management of the Company.

Ping Tse

Mr. Tse Ping serves as Chief Executive Officer, Executive Director of the Company. He is responsible for the overall operations of the Group. With more than 25 years of extensive experience in investment and management in the pharmaceutical industry in China, he is currently a director of CT Tianqing, NJCTT, Jiangsu CT Fenghai, Jiangsu CT Qingjiang, Qingdao CT, and Beijing Tide. He is also a director of Shanghai Fortune World Development Co., Ltd., Tianjin Chiatai Feed Tech Co., Ltd., SYN Energy Technology Co., Ltd. and Chia Tai Oversea Chinese Realty Development Co., Ltd., and a non- executive director of Tianjin Binhai Teda Logistics (Group) Corporation Limited, the shares of which are listed on GEM Board of the Stock Exchange. Mr. Tse still acts as a director of Chia Tai Qingchunbao Pharmaceutical Co., Ltd. and a council member of the Association of Pharmaceutical Biotechnology of China.

Cheung Ling Cheng

Ms. Cheng Cheung Ling serves as Executive Vice Chairlady of the Board of Sino Biopharmaceutical Ltd. Ms. Cheng graduated from the Guanghua School of Management of Peking University and obtained a Master Degree in Business Administration. She is a clinician. Ms. Cheng has extensive experience in and a discerning vision for management and investment in the pharmaceutical industry. She spares no effort in promoting innovation and R&D capabilities in the industry. She is the chairman of Beijing Tide. Being at the helm of Beijing Tide, Ms. Cheng advocates for innovations in R&D, production, sales, and management, and has led Beijing Tide to step up its efforts in developing international collaboration, with an aim to promote rapid development of cutting-edge technologies for medical products in China, and to give top priority to quality control, considering product quality as the lifeblood of the company. Under her leadership, Beijing Tide has achieved tremendous growth, riding on internationalization and innovation. Beijing Tide has become a leading company for the development of targeted drugs in China, being ranked one of the “Top 50 Pharmaceutical Companies in China” (based on data of Ministry of Industry and Information Technology for 2016) and the 4th place of “Pharmaceutical Industry Enterprises with Most Investment Value in the PRC” (awarded by National Pharmaceutical Industry Information Annual Conference 2017).

Minggang Wang

Mr. Wang Minggang serves as Vice Chairman of the Board and the General Manager of Qingdao Haier of Sino Biopharmaceutical Ltd. He is a Master degree postgraduate, a practicing doctor and a senior engineer, and is the vice president and the general manager of Qingdao CT. Mr. Wang joined the Group in September, 2008. He had worked in some large domestic and foreign pharmaceutical companies and was the general manager of Qingdao Haier Pharmaceutical Co. Ltd and the head of the biological division of the Haier Group. He has more than 30 years of management experience in pharmaceutical industry. Mr. Wang is the chairman of Qingdao Pharmaceutical Profession Association, a vice chairman of the Shandong Province Pharmaceutical Profession Association, as well as a delegate to the Committee of the 15th and 16th Chinese People’s Political Consultative Conference of Qingdao City. Mr. Wang has received various recognitions in recent years, such as Qingdao Distinguished Talent, Shandong Province Technology Advancement Second Honour Award, Qingdao Technology Advancement Third Honour Award, and Shangdong Province Invention and Entrepreneurship First Honour Award.

Chun Ling Li

Ms. Li Chun Ling serves as Vice President - Finance of CT Tianqing of the Company. She is and is responsible for finance and informatization of CT Tianqing. Ms. Li joined the Group in 1996, worked in audit department and finance and accounting department of the Group, and was an accounting manager of the Group. Ms. Li graduated from Guizhou College of Finance and Accounting. She had worked in audit firms and served as a team in-charge for social auditing of projects. Ms. Li has over 20 years of experience in finance and accounting, and is a certified accountant in the PRC.

Hsin Tse

Mr. Tse Hsin serves as Executive Director, Vice President of Sino Biopharmaceutical Ltd. He is mainly responsible for the acquisition and merger activities of the Group. He is also the Group’s spokesman. Mr. Tse Hsin graduated from the University of Hong Kong with a Bachelor’s Degree (Honors) in Industrial Engineering. He joined the Group in August, 1995 as an assistant to the president of the Company and served as the general manager of Xian C.P. Pharmaceutical Co., Ltd. Mr. Tse Hsin is a council member of the first council and the executive council member of the second council of Chaozhou Natives Chamber of Commerce Beijing. He is also an executive member of the Right Protection Association for the Medical Treatment Equipment Enterprises of the Shaanxi Province, the vice chairman of the fourth council of the Foreign Invested Enterprises Association of the Shaanxi Province, the executive member of the third committee of the Shaanxi Cancer Fighting Association and the vice chairman of the World Chinese Medicine and Pharmaceutical Professional Joint Committee. He was also awarded the “Outstanding Management Award for Foreign-invested Enterprises of Shaanxi Province” and “Outstanding entrepreneur who cares about his staff” by the Shaanxi Provincial Government. He was an executive director of Beijing Tide. He is currently a director of CT Tianqing, NJCTT, and Qingdao CT and the president of Chia Tai Shaoyang Orthopedic Hospital. He is an uncle of Miss Tse, Theresa Y Y, the Chairlady of the Board, and a first cousin of Mr. Tse Ping, an Executive Director and a substantial shareholder of the Company. He is also the brother of Miss Tse Wun and a first cousin of Ms. Chia Fai and Mr. Tse Hsuan, Johnny, all being senior management of the Company.

Mingqin Li

Ms. Li Mingqin serves as Vice President, Executive Director of Sino Biopharmaceutical Ltd. She is currently a vice president of the Company and a director of Beijing Tide, Chia Tai Shaoyang Orthopedic Hospital and CP Boai Investment Ltd., and is principally responsible for the investment affairs of the Group. Ms. Li graduated from the Faculty of Medicine of Beijing Chinese Medicine University with a Bachelor Degree in medicine. Prior to joining the Company, Ms. Li had worked in Sino-Japanese Friendly Hospital and Beijing Chinese Medicine University, engaged in teaching of medicines, development of new medicines and medicine management. During the period from 1992 to 1995, Ms. Li had been engaged in post-doctorate research in the Medicine School of University of Colorado, USA and the Medical College of the University of Massachusetts. Ms. Li joined the Group in March, 1997 and has 35 years of experience in the pharmaceutical industry.

Fai Chia

Ms. Chia Fai serves as Assistant to the President and Vice President of Sino Biopharmaceutical Ltd. Ms. Chia joined the Group in November, 1991 and has more than 28 years of experience in finance and accounting. Ms. Chia is a director of various companies including Chia Tai Pharmaceutical (Lianyungang) Company Limited, Evon Industries Limited, Talent Forward Limited, Sino Biopharmaceutical (Beijing) Limited and Magnificent Technology Limited.

Jinming Li

Mr. Li Jinming serves as Vice President of CT Tianqing of the Company. Mr. Li studied pharmacology major at Chinese Pharmaceutical University, and holds an MBA degree awarded by Sun Yat-sen University. Mr. Li joined the Group in June, 2006 and is in charge of marketing, planning, medical, and training affairs. He had worked as major district manager and deputy general manager in two well-known pharmaceutical enterprises in the PRC and has extensive sales and team management experience.

Xiquan Zhang

Mr. Zhang Xiquan serves as Vice President of R&D of CT Tianqing and Director of the CT Tianqing R&D Institute of Sino Biopharmaceutical Ltd. Mr. Zhang is a vice president in R&D of CT Tianqing and the director of the CT Tianqing R&D Institute. Mr. Zhang graduated from the chemistry department of Nankai University with a Master of Science degree in 1994. He takes charge of a number of studies of new drugs with expertise in drug candidate selection and joint development with collaborators. Mr. Zhang joined CT Tianqing in April, 1997. Being a leader of R&D of CT Tianqing, he was inducted into talents development programmes including Jiangsu Province Young and middle aged Experts with Outstanding Contribution, Six Categories of Talents Summit, and Jiangsu Province 333 Talents Project, and was awarded the National Technology Advancement Second Honour Award, the Jiangsu Province Technology Advancement Second Honour Award, and the Shanghai Technology Advancement Second and Third Honour Awards.

Xinglong Zhuang

Mr. Zhuang Xinglong serves as Vice President of CT Tianqing of the Company. Mr. Zhang graduated from the chemistry department of Nankai University with a Master of Science degree in 1994. He takes charge of a number of studies of new drugs with expertise in drug candidate selection and joint development with collaborators. Mr. Zhang joined CT Tianqing in April, 1997. Being a leader of R&D of CT Tianqing, he was inducted into talents development programmes including Jiangsu Province Young and middle aged Experts with Outstanding Contribution, Six Categories of Talents Summit, and Jiangsu Province 333 Talents Project, and was awarded the National Technology Advancement Second Honour Award, the Jiangsu Province Technology Advancement Second Honour Award, and the Shanghai Technology Advancement Second and Third Honour Awards.

Fajun Cai

Mr. Cai Fajun is General Manager of the sales Department of CT Tianqing of the company. Mr. Cai studied drug analysis in Wuxi Medicine College and graduated from the Beijing Technology and Business University with a Bachelor degree in management. Mr. Cai joined the Group in April, 1997, and had been working in production and sales departments. He has nearly 30 years of practical experience in medicine production and sales, and has shrewd market acumen and rich sales and management experience.

Ren Li

Ms. Ren Li is General Manager - of Qingdao CT of the company. She is graduated from medicinal chemistry faculty of Ocean University of China and is a PhD fellow, a practicing pharmacist, and a senior engineer. She is the general manager of Qingdao CT. Ms. Ren joined the then Qingdao Haier Pharmaceutical Co. Ltd. in 1997 after her graduation, responsible for new drugs development, and had been its head of R&D, the head of marketing, and a deputy general manager. She has gained more than 20 years of experience in pharmaceutical industry for new drugs development and management. Ms. Ren is an executive vice chairman of the marine medicine specialist committee of Qingdao Pharmaceutical Association, an executive vice chairman of the medicine engineering specialist committee of Qingdao Pharmaceutical Association, and an executive member of the editorial board of the Chinese Journal of Osteoporosis. Awards and recognitions received by Ms. Ren in recent years include Distinguished Talent of Qingdao Xihaian New District, Shandong Province Technology Advancement Second Honour Award, and Qingdao Technology Advancement Third Honour Award.

Haihua Liu

Mr. Liu Haihua is General Manager - of Jiangsu CT Fenghai of the company. He is a deputy general manager of Jiangsu CT Fenghai, the president of its labour union, and a senior engineer. Mr. Liu studied chemistry in university, completed a postgraduate MBA programme of Renmin University of China, and in 2007, took part in the Thousand Talents programme of the Jiangsu Province in Hong Kong. He had been the head of equipment, the head of production, an assistant to factory director, a deputy sales director, and a deputy director of production quality control. With 20 years’ experience in management, he has profound knowledge in production quality control, corporate management, and project management, and has published various articles in major national journals.

Xiaoguang Shen

Mr. Shen Xiaoguang serves as Assistant to President and the General Manager of the Investment Management Department of the Company. Mr. Shen participates in business development and management as well as mergers and acquisitions for medical and healthcare projects of the Group. Mr. Shen graduated from the Heilongjiang College of Business with a Bachelor degree in pharmaceutical manufacturing, and also holds an MBA degree from the Business School of Central University of Finance and Economics. He has 19 years of experience in pharmaceutical marketing, product R&D and manufacture, and management and operations of medical projects. Mr. Shen joined the Group in February, 2003.

Wenjun Shi

Mr. Shi Wenjun is Mr. Shi is the general manager of the sales department (division 3) of CT Tianqing. Mr. Shi studied Chinese Language in Nanjing Normal University and obtained a Master degree in human resources management from Xiamen University. Mr. Shi joined the Group in April, 1997 and had been a director and a deputy general manager. He has over 20 years of experience in sales and management of pharmaceutical products, having shrewd sense of market conditions and insightful and precise views.

Hsuan Tse

Mr. Tse Hsuan (Johnny) serves as General Manager - Information Management Department of Sino Biopharmaceutical Ltd. He joined the Group in January, 2003, and is mainly responsible for the development and maintenance of the information system of the Company. Mr. Tse graduated from the University of Oregon with a Bachelor degree in computer science in the United States. He also studied at ESMOD (Ecole International de Mode Paris) in Paris of France with a diploma in fashion design and pattern drafting. Before joining the Company, Mr. Tse worked in Beijing Major Kind Co., Ltd. as a designer and a manager of information department. His design of uniform for air attendants was adopted by Air China.

Hong Wang

Mr. Wang Hong serves as General Manager - Channel Division of CT Tianqing of the Company. Mr. Wang graduated from Shanghai Medical University with a Master degree in medical science in 1991, and also holds an MBA degree from the Business School of the National University of Singapore. Mr. Wang joined the Group in December, 2002, and was a director of marketing and a deputy general manager. He had been the Derm Franchise Sales Manager of Xian-Janssen Pharmaceutical Ltd. for 8 years. Mr. Wang has more than 20 years of experience in sales.

Qiang Yao

Mr. Yao Qiang is General Manager of Sales Department of CT Tianqing of the company. He graduated from East China University of Science and Technology and holds an MBA degree. Mr. Yao joined the Group in April, 1997 and had been a sales director and a duputy general manager. He has extensive practical experience in sales and management, with advanced team management concepts and innovative sales management means.

Wei Nong Ye

Dr. Ye Wei Nong, Ph.D., is Assistant President, General Manager - R&D Department, subsidiary of Sino Biopharmaceutical Ltd. He is responsible for biotechnology development of the Group. He is currently a director of China Biotech & Drug Development Limited and Jiangsu CT Fenghai. In 1983, Dr. Ye graduated from Sun Yat-sen University with a Bachelor degree in biochemistry. In 1989, Dr. Ye obtained a doctoral degree in microbiology from the Institut National des Sciences Appliquees (INSA) de Toulouse of France. He also obtained a certificate of study for the post-graduate MBA programme of food technology and marketing from Ecole Superieure de Commerce (ESC) de Toulouse of France. Prior to joining the Group in July, 2002, he worked in Europe and Hong Kong for biotechnology and pharmaceutical companies. Dr. Ye was a member of the Advisory Committee on Applied Biology and Chemical Technology of The Hong Kong Polytechnic University from February, 2006 to September, 2014. He was a council member of the 8th Subcommittee of Industrial Biochemistry and Molecular Biology under the Chinese Society of Biochemistry and Molecular Biology.

Yong Zhu

Mr. Zhu Yong serves as General Manager of Jiangsu Qingjiang of the Company, He has been the marketing director of Jiangsu CT Fenghai since 2005, and is mainly responsible for marketing and academic promotion of new products, establishing the brand name of Fenghai and formulating successful marketing strategies for leading and developing market which resulted in the widespread recognition of the image of “New Model of Sugar Infusion Solution” of Jiangsu CT Fenghai by the pharmaceutical industry. In 2008, as a sales vice president, he initiated Jiangsu CT Fenghai’s characteristic mixed marketing model with success. In 2011, he was the executive vice president of Jiangsu CT Fenghai, responsible for R&D, marketing and human resources, having set up a drugs R&D centre in Nanjing and established the training system for all levels of staff. In October, 2014, he was appointed as the executive vice president of Jiangsu CT Qingjiang and was responsible for R&D, human resources and office administration. From January, 2015 onwards, he is the general manager and is responsible for overall management of Jiangsu CT Qingjiang, having successfully re-engineered the sales system, proposed the “RMB100 million” strategy for key products, and driven the sales of products like Glucosamine Hydrochloride and Cefaclor and Bromhexine Hydrochloride to exceed the RMB100 million mark. He was awarded a May 1 Labour Medal by the Huian City Peoples’ Government in 2015 and recognized as a Jiangsu Province Distinguished Manager for User Satisfaction in 2017.

Yangsheng Chen

Mr. Chen Yangsheng is Deputy General Manager - of R&D of Qingdao CT of the company. He graduated from chemistry department of Wuhan University and is a postgraduate student, a practicing pharmacist, and a research associate. He is a deputy general manager of R&D of Qingdao CT. Mr. Chen was engaged in new drugs development with the National Institute of Pharmaceutical Research and Development Center after his graduation in 1993, and joined the then Qingdao Haier Pharmaceutical Co. Ltd. as the head of R&D in 1998. He has 25 years of experience in new drugs development and management. Mr. Chen is a review expert of the national provincial level technology projects, an executive vice chairman of the medicinal chemistry specialist committee of Qingdao Pharmaceutical Association, and a council member of Qingdao Marine Biomedical Technology Innovation Center. Awards and recognitions received by Mr. Chan in recent years include Qingdao Municipal Government Expert Special Allowance, Shandong Province Technology Advancement Second Honour Award, Qingdao Technology Innovation Second Honour Award, and Qingdao Technology Advancement Third Honour Award.

Kuanqi Wang

Mr. Wang Kuanqi serves as Senior Deputy General Manager - NJCTT of the Company. He is the senior deputy general manager of NJCTT and is in charge of production. Mr. Wang graduated from Changzhou Chemical Institute with the profession qualification in organic synthesis. He joined CT Tianqing in 1988. He holds a Bachelor degree in pharmacology from China Pharmaceutical University and an EMBA degree from both of Shanghai Fudan University and National Taiwan University. He was a team leader and an officer of production lines, a production manager and an assistant to general manager.

Yangqing Zhang

Mr. Zhang Yangqing serves as Deputy General Manager of Finance Department of NJCTT of the Company. He is currently a deputy general manager of finance department of NJCTT. He graduated from the engineering management faculty of Central South University with a Bachelor degree in industrial engineering management in 1990. He is a senior accountant, a certified accountant and a practicing registered real estate appraiser. He was a member of National Development and Reform Commission of Ziyang District of Yiyang City in Hunan Province, a civil servant of Housing Administrative Bureau of Yiyang City, an audit manager of Hunan Kaiyuan CPA, a financial controller of Chengdu Jiuzhitang Jinding Pharmaceutical Ltd., a deputy head of finance department and a director of marketing centre of Jiuzhitang Co., Ltd., the head of audit department of CT Tiangqing, a finance manager of the Group, and a deputy general manager of finance department of Jiangsu CT Fenghai.

Zhenqian Zhang

Mr. Zhang Zhenqian serves as Executive Deputy General Manager - NJCTT of the Company. He is the executive deputy general manager of NJCTT. He is an engineer and holds an MBA degree. Mr. Zhang joined the Group in April, 1997 and is responsible for marketing and sales and operations of NJCTT. Graduated from Xuzhou College of Engineering, Mr. Zhang has completed the studies in EMBA program of Guanghua Management School of Peking University. Mr. Zhang was a branch manager and a major district manager of CT Tianqing and has over 20 years of experience in pharmaceutical industry.

Sheng Chen

Mr. Chen Sheng is Financial Controller and Deputy General Director of the company. He graduated from the accounting department of Nanjing University of Finance & Economics with a Bachelor degree in management, and is a certified registered tax agent in PRC, a certified accountant and a senior accountant. Mr. Chen joined Jiangsu CT Qingjiang in July, 2012 as an assistant to financial controller and is now a deputy general manager and the financial controller. During his tenure, Mr. Chen actively promotes the transformation and upgrade of finance management services to support sales activities with success. Under his management, the results of the company have continuously improved and the company was ranked as one of the top 50 tax contributors in the region in 2017. Mr Chen has extensive management experience in finance.

Chau Ling Yu

Ms. Yu Chau Ling, CPA, FCCA, is Assistant Vice President, Financial Controller of Sino Biopharmaceutical Ltd. She is an assistant vice president, the financial controller and the qualified accountant of the Company. She graduated from the University of Hong Kong with a Bachelor degree in social sciences and in 2005 obtained an MBA Degree from The Open University of Hong Kong. She is a fellow member and an associate member of the Association of Chartered Certified Accountants and the Hong Kong Institute of Certified Public Accountants, respectively. Ms. Yu joined the Company in February, 2003 and has extensive working experience in international audit firm and listed companies.

Zhoushan Tian

Mr. Tian Zhoushan serves as Executive Director of the Company. joined the Group in April, 1997 and is responsible for the business of NJCTT. Mr. Tian is currently the general manager of NJCTT. Mr. Tian completed MBA coursework in Nanjing University. He was the head of production, the assistant to the president, and the vice president of CT Tianqing, and has 29 years of experience in the pharmaceutical industry.

Shanchun Wang

Mr. Wang Shanchun serves as Executive Director of Sino Biopharmaceutical Ltd. He graduated from Nanjing University of Chemistry in July, 1990 and joined CT Tianqing in the same year. Mr. Wang studied pharmaceutical engineering with Tianjin University from 1999 to 2002 and obtained a Master Degree. Mr. Wang has extensive management experience in the PRC pharmaceutical field. His design of the new production plant of CT Tianqing in Haizhou achieved a number of innovations in the country and obtained the first new edition national GMP certificate. He was awarded as a Jiangsu Province Technology Advanced Worker, a Jiangsu Province Model Labour, a winner of the Shanghai Technology Advancement First Honour Award, a Jiangsu Province Outstanding Entrepreneur, a Jiangsu Province Young and Middle-aged Expert with Outstanding Contribution, a Jiangsu Advanced Individual with Outstanding Contribution in Manufacture, and a National Distinguished Leader in Pharmaceutical Quality Management, and was elected as a delegate to Committee of the 13th Chinese People’s Political Consultative Conference of Jiangsu Province.

Hui Cheng

Ms. Cheng Hui serves as Deputy Financial Controller of Sino Biopharmaceutical Ltd. Ms. Cheng joined the Group in May, 1993 and is responsible for the Group’s PRC finance and human resources. She was Ms. Cheng joined the Group in May, 1993 and is responsible for the Group’s PRC finance and human resources. She was the head of the finance department in China Construction Bank (Zaozhuang City Branch). Ms. Cheng has 27 years of working experience in finance and accounting. She was awarded the accountancy qualification certificate issued by Ministry of Finance and Ministry of State Personnel, and the ACCA Chinese finance and accounting qualification certificate issued by the Association of Chartered Certified Accountants. Ms. Cheng received international advanced human resources management professional training held by the International Public Management Association for Human Resources (IPMA-HR) and advanced training for PRC financial investment held by the School of Economics of Peking University.

Zhaoshu Gu

Ms. Gu Zhaoshu is Senior Engineer of the company. She is graduated from East China University of Science and Technology and holds a Master degree in biochemical engineering. She is a senior engineer and holds a practicing pharmacist certificate. Ms. Gu joined Shanghai Tongyong Pharmaceutical Co., Ltd. in April, 2011. She was the director of quality control and is a deputy general manager of manufacture and the factory director. She has more than 30 years of management experience in pharmaceutical industry.

Fangzhui Hu

Mr. Hu Fangzhui is a vice president of CT Tianqing and is in charge of the finance and accounts sharing centre. Mr. Zhang graduated from the finance department of Nanjing University of Finance & Economics in July, 1995. Mr. Hu joined the Group in April, 1999, and has nearly 20 years of work experience. He has participated in and led many finance information platform projects and has extensive experience in management practices and finance informatization.

Zong Liu

Mr. Liu Zong is Senior Engineer of the company. He holds a Bachelor degree in science from China Pharmaceutical University. Mr. Liu joined Jiangsu CT Qingjiang (previously known as Jiangsu Province Qingjiang Pharmaceutical Factory) in July, 1989. He was appointed as an assistant to general manager in 2000 and was responsible for quality control and new products development, helping the company obtain the GMP certificate for company relocation smoothly. He has been a deputy general manager and the secretary of board of directors of Jiangsu CT Qingjiang since 2004, being in charge of international trade of medicinal raw materials, product sales, and new products development and having successfully developed overseas market. He has rich experience in pharmaceutical industry.

Kong Tai

Mr. Kong Tai is Managing Director Of Beijing Tide of the company. He is the managing director of Beijing Tide. He is a member of the Chinese People’s Political Consultative Conference (Beijing Daxing District), a deputy chairman of each of the All-China Federation of Industry and Commerce for Pharmaceuticals, China Pharmaceutical Industry Association, and Beijing Pharmaceutical Profession Association, an executive council member of Chinese Hospital Association, and a visiting professor of Heilongjiang University of Chinese Medicine. Mr. Kong graduated from Heilongjiang University of Chinese Medicine with a Bachelor degree. Mr. Kong joined Beijing Tide in February, 2013 as the managing director. He has ample practical management experience, and was recognized as a Best Leader in Pharmaceutical Fields in the World, a Leading Figure of Innovative Engineering – Beijing Yiqilun, one of the Top 10 Innovative Persons in the Pharmaceutical Industry in China for 2014 and 2015, an Influential Person in the Industry for 2016, and one of the Top 10 Leading Figures in the Pharmaceutical Industry in China for for 2016.

Zhaocheng Tang

Mr. Tang Zhaocheng serves as Vice President - CT Tianqing of Sino Biopharmaceutical Ltd. He is responsible for the affairs of the Party and labour union of CT Tianqing, and the general manager of LYG Runzhong. Mr. Tang joined CT Tianqing in April, 1997. He has a professional qualification in chemical engineering. Mr. Tang has been engaged in medicine production for more than 20 years, and has extensive experience in pharmaceutical production, quality control, and process advancement. He was awarded as a National Advanced Individual in Quality Control and a Jiangsu Province Outstanding Entrepreneur and was granted special allowance by the Lianyungang government.

Wun Tse

Ms. Tse Wun serves as Assistant to the President of Sino Biopharmaceutical Ltd. Ms. Tse joined the Group in November, 1991. She is mainly responsible for administration, finance and investment affairs of the Group’s Hong Kong office. Ms. Tse graduated from the University of Oregon with a Bachelor of Science degree. She was formerly a director of Shenzhen 999 Pharmaceutical Co., Ltd. and has more than 20 years of experience in finance and investment.

Hongqi Wang

Mr. Wang Hongqi is Deputy General Manager of NJCTT of the company. He is the deputy general manager of NJCTT, and is responsible for business affairs and sales. Mr. Wang graduated from the accounting faculty of Xuzhou School of Supply and Marketing and obtained a MBA degree from Nanjing University. Mr. Wang joined the Group in July, 2002 and had been its branch manager, major district manager, and sales director. He has rich experience in sales management, with nearly 20 years of experience in pharmaceutical sales.

Xiangjian Wang

Mr. Wang Xiangjian serves as Vice President of CT Tianqing of the company. He graduated from Nankai University and holds a Bachelor degree in molecular biology. Mr. Wang joined the Group in April, 1997 and is responsible for clinical monitoring and new medicine registration of CT Tianqing R&D Institute. He was inducted into the Lianyungang 521 talents development programme.

Wenyu Xia

Mr. Xia Wenyu serves as General Manager and Director of Jiangsu Fenghai of the company. He has a professional qualification in finance and accounting discipline at tertiary education level and is a Senior Economist. He graduated from the post-graduate MBA programme of the Renmin University of China. He has been the general manager and a director of Jiangsu CT Fenghai since September, 2014 and previously served as the head of finance department, deputy head of corporate restructuring committee, manager of financial planning department, board secretary, assistant to general manager and manager of logistic department, sales director, and deputy general manager of Jiangsu Fenghai. He has ample experience in corporate management, marketing, human resources and financial management and has over 30 years of experience in the pharmaceutical industry. He is the vice president of the Jiangsu Province Pharmaceutical Profession Association and a standing council member of the China Price Association and the Jiangsu Province Medical Insurance Committee.

Ziping Xu

Mr. Xu Ziping is Senior Engineer of the company. He graduated from Tongji University and holds a doctoral degree in engineering management. He is a senior engineer and a senior economist. Mr. Xu joined Shanghai Tongyong Pharmaceutical Co., Ltd. in December, 2016 as the general manager. Mr. Xu had worked in reputable pharmaceutical companies in the PRC as deputy general manager, vice president, and general manager. He has more than 20 years of ample management experience in pharmaceutical industry.

Jie Zhang

Mr. Zhang Jie serves as Vice President - CT Tianqing of the Company. He graduated from Nanjing University and holds an MBA degree. Mr. Zhang joined the Group in April, 1997 and is responsible for policy matters, human resources, legal affairs, and public relations of CT Tianqing. He holds positions in a number of pharmaceutical profession associations and has rich research results on national medicines policies, in particular the policies for medical insurance and healthcare reform.

Ling Zhang

Mr. Zhang Ling is Deputy General Manager and the Secreatary to the board of directors of NJCTT of the company. He is a deputy general manager and the secretary to the board of directors of NJCTT, being responsible for human resources and board related affairs. Mr. Zhang graduated from the refined chemicals department of Zhengzhou Food Institute (now known as Zhengzhou Institute of Engineering) with a Bachelor degree in engineering. Mr. Zhang joined NJCTT in September, 2002, having served as a director of the general manager office, human resources director, assistant to general manager, etc., and has been the secretary to the board of directors since then. He has more than 10 years of experience in administration and human resources management, with profound knowledge of human resources management.

Oi Nin Chan

Mr. Chan Oi Nin Derek CPA serves as Company Secretary of the Company since August, 2015. Chan has nearly 20 years of experience in accounting and auditing and, before joining the Company, was the company secretary of another company listed on the Stock Exchange. He is a fellow member of the Association of Chartered Certified Accountants and an associate member of the Hong Kong Institute of Certified Public Accountants. Mr. Chan received a Bachelor of Science degree from the Chinese University of Hong Kong in 1989 and an MBA degree from Monash University in 1995. .

Dakui Li

Mr. Li Dakui serves as Independent Non-Executive Director of Sino Biopharmaceutical Ltd. He joined the Company as an independent non-executive director and a member of the Audit Committee of the Company in September, 2004. He graduated from the Faculty of Pharmacy of Beijing Medical University (now known as the School of Pharmaceutical Sciences of Beijing University) in 1965, and obtained a Master Degree in Pharmaceutics from Peking Union Medical College (“PUMC”) in 1982. He used to be the chief pharmacist of PUMC Hospital (retired in 2013) and the director of Pharmacy Department of PUMC Hospital for years. Mr. Li was a vice president of the Chinese Pharmaceutical Association, the Chairman of the Committee of Hospital Pharmacy Branch of Chinese Pharmaceutical Association and the vice chairman of the Chinese Practicing Pharmacist Association. He is currently an advisory member of the Chinese Pharmaceutical Committee and a vice president of the Beijing Pharmaceutical Association.

Hong Lu

Ms. Lu Hong serves as Independent Non-Executive Director of the Company. joined the Company as an independent non-executive director and a member of the Audit Committee, the Remuneration Committee and the Nomination Committee of the Company in April, 2015. Ms. Lu has over 20 years of experience in accounting, financial management, company secretary and domestic and overseas capital operations fields. She is a member of the Chinese Institute of Certified Public Accountants and the Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of Chartered Certified Accountants. Ms. Lu has extensive knowledge of PRC and international accounting standards and the listing rules and regulations of both Hong Kong and PRC. She has been in charge of or involved in the entire process of the listing of multiple corporations in the PRC, Hong Kong, Singapore and the United States of America and quite a number of foreign and domestic investment and financing operations as well as mergers and acquisitions. She is familiar with financial analysis, budgeting, financial management and tax planning. She also has expertise in dealing with complex financing and taxation matters. Ms. Lu is an independent non-executive director of Huan Yue Interactive Holdings Limited which is listed on the Stock Exchange.

Zhengfei Lu

Mr. Lu Zhengfei serves as Independent Non-Executive Director of Sino Biopharmaceutical Ltd. He is the Chairman of the Audit Committee and a member of the Remuneration Committee and the Nomination Committee of the Company. He received a P.h.D. Degree in Economics (financial management). Mr. Lu is currently a Distinguished Professor of Chang Jiang Scholars and supervisor of doctoral students of the Guanghua School of Management of Peking University. He had previously held various senior positions in the Department of Accounting of both Peking University and Nanjing University. He is a standing council member of the China Accounting Association and the deputy director of its Financial Management Committee and was also an expert consultant of the China Financial Accounting Standards Board, Ministry of Finance. Mr. Lu is the editor of several accounting and finance journals and has issued various publications. He is an independent non-executive director of Bank of China Limited, China National Materials Company Limited and Sinotrans Limited and an independent supervisor of PICC Property and Casualty Company Limited, shares of all four companies being listed on the Stock Exchange.

Lu Fu Zhang

Mr. Zhang Lu Fu serves as Independent Non-Executive Director of the Company. He joined the Company as an independent non-executive director and the chairman of the Remuneration Committee and a member of the Nomination Committee of the Company in April, 2015. Mr. Zhang holds a Master Degree in Philosophy from the Beijing Normal University, and is currently a research associate and a part-time professor. Mr. Zhang has been working for multiple sectors of the Chinese government since 1987, including the Hong Kong branch of the Xin Hua News Agency (now known as Liaison Office of the Central People’s Government in Hong Kong). Mr. Zhang has worked for a number of Hong Kong listed companies and charitable organizations on full-time and part-time bases. Mr. Zhang is a council member of the China Overseas Friendship Association, a standing council member of the Guangdong Overseas Friendship Association, a standing council member of the Shenzhen Overseas Friendship Association, a member of the Shenzhen Committee of the 4th Chinese People’s Political Consultative Conference, and a part-time professor of the Hong Kong Academy of Management. Mr. Zhang is an independent non-executive director of Kingboard Laminates Holdings Limited and CT Environmental Group Limited, both being listed on the Stock Exchange.